TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain

Anja Schlecht1, Mario Vallon1, Nicole Wagner1

  • 1Institute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.

Biomolecules
|September 28, 2021
PubMed

Insights

Ischemic insults harm the heart, brain, and retina. This review explores how transforming growth factor beta (TGFβ) and neurotrophins regulate these organs, potentially protecting them from damage.

Area of Science:

  • Cardiovascular Science
  • Neurology
  • Ophthalmology

Background:

  • Ischemic insults to the heart and brain (myocardial and cerebral infarction) are leading global causes of death.
  • Retinal ischemia drives neovascular eye diseases like diabetic retinopathy (DR) and age-related macular degeneration (AMD), leading to blindness.
  • The retina serves as a 'window' to assess microvascular damage in systemic diseases like diabetes and hypertension.

Purpose of the Study:

  • To review the intricate heart-brain and brain-retina axes.
  • To focus on the roles of transforming growth factor beta (TGFβ) and neurotrophins in regulating these axes.
  • To discuss their involvement in inflammation and repair following ischemic/neovascular insults.

Main Methods:

  • Literature review focusing on the heart-brain and brain-retina axes.
  • Analysis of the roles of TGFβ and neurotrophins in physiological and pathological conditions.
  • Discussion of potential cross-talk between TGFβ and neurotrophin signaling.

Main Results:

  • The heart, brain, and retina exhibit complex neuronal and endocrine interactions.
  • TGFβ and neurotrophins play critical roles in regulating these interconnected axes.
  • Evidence suggests TGFβ signaling influences neurotrophin expression.

Conclusions:

  • Cross-talk between TGFβ and neurotrophin signaling may offer cellular protection against ischemic/neovascular damage.
  • Understanding these axes is crucial for developing therapies for cardiovascular, neurological, and ophthalmological diseases.
  • Further research into TGFβ and neurotrophin interactions could reveal novel therapeutic targets.